AstraZeneca Unveils Sweeping Blood Cancer Push With Record ASH Presence
WILMINGTON, DE — AstraZeneca plc (Nasdaq: AZN) is sharply expanding its ambitions in hematology and cell therapy, unveiling new clinical data across blood cancers as it makes its largest-ever showing …
AstraZeneca Unveils Sweeping Blood Cancer Push With Record ASH Presence Read More